Autobio BV assay is a rapid test which is used in the obstetrics and gynecology divisions in a health care institution, or used prior to a surgery, for the detection of bacterial vaginosis and the monitoring of therapies.
BV is a synergistic polymicrobial syndrome characterized by a depletion of normal flora in the vagina such as Lactobacillus species and an increase in the quantities of vaginal anaerobic bacteria such as Gardnerella vaginalis, Bacteroides, Mobiluncus, etc. BV is one of the most common gynecopathies and relapses easily. 50 percent BV patients are easy to give premature birth or deliver low-birth-weight infants. Their babies may possibly suffer from all kinds of sequelae. BV is a risky factor leading to chorioamnionitis, amniotic fluid infection, endometritis infected following caesarean birth, bad pregnancy and some pregnancy-related complications. Besides, BV is mainly related to salpingitis, pelvic inflammatory disease, entopic pregnancy, infertility, urinary tract infection, surgical infection and female tumor. Due to these harms to women and pregnancy, it is of great clinical significance to test BV in obstetrics, gynecology and prior to surgical abortion. However, as BV is not a single germ infection but a polymicrobial infection, the clinical diagnosis is due to this made difficult.
This assay is rapid, does not require special instrument, is highly sensitive, easy to operate and accurate. The results are easy to be distinguished and the cost is low. The clinical evaluation showed the agreement with Amsel method (Gold standard) is above 90%. It has valuable clinical utility, suitable for hospitals and clinics of all levels and all types.
